Literature DB >> 8025439

Thalidomide may be a mutagen.

W G McBride.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 8025439      PMCID： PMC2540455          DOI： 10.1136/bmj.308.6944.1635b

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  2 in total

1.  Another, late thalidomide abnormality.

Authors:  W G McBride
Journal:  Lancet       Date:  1981-08-15       Impact factor: 79.321

2.  Thalidomide induced alteration in secondary structure of rat embryonic DNA in vivo.

Authors:  P H Huang; W G McBride
Journal:  Teratog Carcinog Mutagen       Date:  1990
  2 in total
  8 in total

1.  Thalidomide is not a human mutagen.

Authors:  J Ashby; H Tinwell
Journal:  BMJ       Date:  2002-11-23

2.  Mutations at the SALL4 locus on chromosome 20 result in a range of clinically overlapping phenotypes, including Okihiro syndrome, Holt-Oram syndrome, acro-renal-ocular syndrome, and patients previously reported to represent thalidomide embryopathy.

Authors:  J Kohlhase; L Schubert; M Liebers; A Rauch; K Becker; S N Mohammed; R Newbury-Ecob; W Reardon
Journal:  J Med Genet       Date:  2003-07       Impact factor: 6.318

3.  Amniotic band sequence in child of thalidomide victim.

Authors:  R Tenconi; M Clementi; L Notari; V R Lo Vasco
Journal:  BMJ       Date:  1994-11-26

4.  Thalidomide may be a mutagen.

Authors:  R W Smithells
Journal:  BMJ       Date:  1994-08-13

5.  Thalidomide may not be a mutagen.

Authors:  M Kida
Journal:  BMJ       Date:  1994-09-17

6.  Does thalidomide cause second generation birth defects?

Authors:  D Smithells
Journal:  Drug Saf       Date:  1998-11       Impact factor: 5.606

7.  [Okihiro syndrome : Duane's syndrome and radial malformations of the limbs].

Authors:  A H Haus; J Kohlhase; B Käsmann; B Seitz
Journal:  Ophthalmologe       Date:  2008-06       Impact factor: 1.059

8.  Diversified clinical presentations associated with a novel sal-like 4 gene mutation in a Chinese pedigree with Duane retraction syndrome.

Authors:  Ming-ming Yang; Mary Ho; Henry H W Lau; Pancy O S Tam; Alvin L Young; Chi Pui Pang; Wilson W K Yip; LiJia Chen
Journal:  Mol Vis       Date:  2013-05-06       Impact factor: 2.367
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.